Cargando…
Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder
RATIONALE: Chronic cannabis use is associated with impaired cognitive function. Evidence indicates cannabidiol (CBD) might be beneficial for treating cannabis use disorder. CBD may also have pro-cognitive effects; however, its effect on cognition in people with cannabis use disorder is currently unc...
Autores principales: | Lees, Rachel, Hines, Lindsey A., Hindocha, Chandni, Baio, Gianluca, Shaban, Natacha D. C., Stothart, George, Mofeez, Ali, Morgan, Celia J. A., Curran, H. Valerie, Freeman, Tom P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879826/ https://www.ncbi.nlm.nih.gov/pubmed/36598543 http://dx.doi.org/10.1007/s00213-022-06303-5 |
Ejemplares similares
-
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder
por: Hua, Daniel Ying-Heng, et al.
Publicado: (2023) -
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?
por: Curran, H. Valerie, et al.
Publicado: (2019) -
Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom
por: Hindocha, Chandni, et al.
Publicado: (2015) -
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
por: Hindocha, Chandni, et al.
Publicado: (2015) -
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
por: Morgan, Celia J. A., et al.
Publicado: (2018)